“KUSA registration and basic vaccination/deworming do not indicate whether a puppy is at risk for inherited health problems, so genetic screening is a separate and necessary step." (Post wording: "A KUSA certificate confirms purebred lineage, not sound genetics or ethical husbandry"; "A standard vet card shows basic deworming and a first…”

KUSA's own published position matches the central claim closely. On its breeders' listing page the registry states that it cannot guarantee that dogs registered with it or their progeny are free from any inheritable or congenital defects, or guarantee any standard of performance, that members are encouraged to do health screening tests prior to breeding, and that the responsibility remains with the purchaser to obtain as much information as possible about the health status of the parents of the litter. The same wording appears in its puppy-buying guidance, which adds that it is a good idea to get copies of the health test results for both parents before paying a deposit. Its consumer explainer states that a KUSA registration cannot guarantee quality, though in most cases it indicates the breeder has taken steps, and lists health tests and DNA screening as separate items to look for. Registration paperwork is not entirely silent on inherited disease, however. KUSA states that results for hip dysplasia and elbow dysplasia are reflected on the Certificate of Registration (Pedigree), whereas all other test results are reflected on the Annex to the Certificate of Registration (Health Certificate) for dogs that have been tested. The specimen certificate reproduced by KUSA shows an Annex carrying hip score, elbow grading, and DNA results including CEA, CMR1, PRA-prcd and MDR1. The registry also applies breed-specific conditions in its registration regulations: its Schedule 02 refers to dogs being proven hereditarily clear of canine leucocyte adhesion deficiency and progressive retinal atrophy rcd1, with all export pedigrees issued with an Annex to the Certificate of Registration reflecting those results, and to requirements that a dog must pass an official HD test and that dam and sire must be DNA-profiled and hold a breed grading of Good or better. KUSA also specifies that dogs must be presented for hip and elbow x-rays at 18 months of age or older. On the breed-specific items: hip and elbow grading is a radiographic assessment of the individual dog, not a DNA test. Hip dysplasia is moderately heritable and, given its welfare impact, has been described as an imperative breeding priority, with the BVA/KC scoring method one of several measures used to assess genetic propensity for dysplastic changes based on radiographic evaluation. In South Africa, the FCI system is used to certify hips and the International Elbow Working Group scheme to certify elbows. For French Bulldogs, the BOAS assessment the post names is a real, defined scheme: the Respiratory Function Grading Scheme was developed by the University of Cambridge and funded by the Kennel Club Charitable Trust to assess dogs for the presence and severity of BOAS, and it uses a sliding scale of 0 to 3, with Grade 0 meaning the dog is clinically unaffected and free of respiratory signs of BOAS. It is a clinical functional assessment, not a genetic test. The OFA has licensed the scheme for use in the United States and Canada. On the DNA tests named: exercise-induced collapse is an autosomal recessive disorder in Labrador Retrievers caused by a point mutation in canine DNM1, and progressive rod-cone degeneration arises from a variant in the PRCD gene. These are breed-relevant tests, principally for Labradors among the three breeds the post names, rather than universal ones.